fenquizone is a medication with anti-inflammatory and analgesic properties. It is primarily used to relieve pain and reduce inflammation. The spectrum of its action is focused on providing relief from pain and inflammation in various conditions, but it is not a broad-spectrum antibiotic or a medication with a wide range of effects like some other drugs. Instead, it is used for its specific anti-inflammatory and analgesic actions.Â
There were no black box warnings associated with fenoverine.Â
Contraindication/Caution:Â
Contraindication:Â
Hypersensitivity: Avoid fenquizone if the patient has a known hypersensitivity or allergy to fenquizone or any of its components.Â
Myasthenia Gravis: fenquizone may worsen the symptoms of myasthenia gravis, a neuromuscular disorder. It is contraindicated in individuals with this condition.Â
Porphyria: fenquizone can trigger acute attacks of porphyria, a group of rare genetic disorders affecting the nervous system or skin. It should be avoided in patients with porphyria.Â
Concurrent Use of Alcohol or CNS Depressants: fenquizone can enhance the depressant effects of alcohol and other central nervous system (CNS) depressants. It should not be used in combination with these substances.
Caution:Â
Hepatic Impairment: fenquizone is metabolized in the liver, and its clearance may be impaired in individuals with liver disease. Use fenquizone with caution in patients with mild to moderate hepatic impairment and avoid it in those with severe impairment.Â
Renal Impairment: Patients with renal impairment should be monitored closely when taking fenquizone. Dose adjustments may be necessary depending on the severity of renal dysfunction.Â
Elderly Patients: Elderly individuals may be more sensitive to the effects of fenquizone. Lower initial doses and careful titration may be required in this population.Â
Cardiovascular Conditions: fenquizone can cause changes in blood pressure and heart rate. Patients with pre-existing cardiovascular conditions should be monitored closely while taking this medication.Â
Pregnancy and Lactation: The safety of fenquizone during pregnancy and breastfeeding is not well-established. It should only be used during pregnancy or lactation if the potential benefits outweigh the risks, and under the guidance of a healthcare provider.
Comorbidities:Â
Respiratory Conditions: fenquizone has the potential to cause respiratory depression, especially at higher doses. Individuals with pre-existing respiratory conditions such as COPD or asthma may be more susceptible to these effects. Careful monitoring is required in such cases.Â
Neurological Disorders: fenquizone can cause dizziness and drowsiness. Individuals with epilepsy or a history of seizures may need extra caution when using this medication.Â
Psychiatric Disorders: Patients with psychiatric disorders, especially those that affect mood or cognition, may experience changes in their mental state while taking fenquizone. Close monitoring is necessary in these cases.Â
Alcohol and Substance Abuse: Patients with a history of alcohol or substance abuse should be closely monitored while using fenquizone, as it may interact with these substances or exacerbate withdrawal symptoms.Â
Pregnancy consideration: pregnancy category: not assignedÂ
Lactation: excreted into breast milk: unknown Â
Pregnancy category:Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.  Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.Â
Category N: There is no data available for the drug under this category.Â
Pharmacology:Â
fenquizone is a medication with muscle relaxant and anti-spasmodic properties. Its pharmacology involves its action on the central nervous system (CNS). fenquizone is thought to work by depressing nerve transmission in spinal cord, which leads to reduced muscle spasms and improved muscle relaxation. It primarily affects the gamma-aminobutyric acid (GABA) neurotransmitter system, increasing inhibitory signals in the CNS. This results in a calming effect on the muscles, reducing muscle tension and spasms. fenquizone is typically used in the treatment of musculoskeletal conditions characterized by excessive muscle contractions and spasticity. Â
Pharmacodynamics:Â
Muscle Relaxation: fenquizone acts centrally in the CNS to reduce muscle tension and spasms. It achieves this by depressing nerve transmission in the spinal cord, which leads to decreased muscle contractions and improved muscle relaxation.Â
Gamma-Aminobutyric Acid (GABA) Modulation: fenquizone is believed to enhance inhibitory effects of neurotransmitter GABA in the CNS. GABA is an important neurotransmitter that reduces neural activity, promoting a calming effect on the muscles.Â
Sedation: One of the side effects of fenquizone is sedation. It can cause drowsiness and may impair cognitive and motor skills. This sedative effect is an important consideration when using the medication.
Pharmacokinetics:Â
AbsorptionÂ
fenquizone is typically administered orally in tablet form. After oral administration, it is absorbed through the gastrointestinal tract. The rate of absorption can vary among individuals and influenced by factors like the formulation of the medication and the presence of food in the stomach.Â
DistributionÂ
Once absorbed, fenquizone is distributed throughout the body. It is likely to cross blood-brain barrier due to its central nervous system effects. Â
MetabolismÂ
The metabolism of fenquizone is not extensively studied, and there is limited information about its metabolic pathways. It is believed to undergo hepatic (liver) metabolism, but the specific enzymes and metabolites involved are not well-characterized.Â
Elimination and excretionÂ
The excretion of fenquizone is primarily through renal (kidney) elimination. Some of the drug and its metabolites are excreted in the urine. The exact elimination half-life and clearance rates may vary among individuals.Â
Administration:Â
Dosage: Take fenquizone exactly as prescribed by your healthcare provider. The dosage can vary based on condition being treated and individual factors. Â
Timing: fenquizone is usually taken with or after meals to minimize stomach upset. Follow your healthcare provider’s recommendations regarding when to take it.Â
Duration: Continue taking fenquizone for the full duration prescribed by healthcare provider, even if your symptoms improve. Stopping the medication prematurely may not effectively manage your condition.Â
Storage: Store fenquizone tablets at room temperature, away from moisture and heat. Follow any specific storage instructions provided with your medication.Â
Patient information leafletÂ
Generic Name: fenquizoneÂ
Pronounced: (fen-kwye-zone)Â Â
Why do we use fenquizone?Â
Pain Relief: fenquizone has been used to alleviate mild to moderate pain, like dental pain, headaches, and musculoskeletal pain.Â
Fever Reduction: It is used to lower fever associated with various illnesses and infections.Â
Inflammation: fenquizone may have anti-inflammatory properties, and it has been used to reduce inflammation in conditions like arthritis.Â
Postoperative Pain: In some cases, it has been used to manage pain after surgical procedures.Â
Rheumatic Conditions: fenquizone has been used to relieve pain and inflammation in certain rheumatic conditions, although its use in this context has diminished over the years.Â
fenquizone is a medication with anti-inflammatory and analgesic properties. It is primarily used to relieve pain and reduce inflammation. The spectrum of its action is focused on providing relief from pain and inflammation in various conditions, but it is not a broad-spectrum antibiotic or a medication with a wide range of effects like some other drugs. Instead, it is used for its specific anti-inflammatory and analgesic actions.Â
Frequency not definedÂ
Electrolyte disturbancesÂ
HypotensionÂ
HeadacheÂ
WeaknessÂ
DizzinessÂ
Black Box Warning:Â
There were no black box warnings associated with fenoverine.Â
Contraindication/Caution:Â
Contraindication:Â
Hypersensitivity: Avoid fenquizone if the patient has a known hypersensitivity or allergy to fenquizone or any of its components.Â
Myasthenia Gravis: fenquizone may worsen the symptoms of myasthenia gravis, a neuromuscular disorder. It is contraindicated in individuals with this condition.Â
Porphyria: fenquizone can trigger acute attacks of porphyria, a group of rare genetic disorders affecting the nervous system or skin. It should be avoided in patients with porphyria.Â
Concurrent Use of Alcohol or CNS Depressants: fenquizone can enhance the depressant effects of alcohol and other central nervous system (CNS) depressants. It should not be used in combination with these substances.
Caution:Â
Hepatic Impairment: fenquizone is metabolized in the liver, and its clearance may be impaired in individuals with liver disease. Use fenquizone with caution in patients with mild to moderate hepatic impairment and avoid it in those with severe impairment.Â
Renal Impairment: Patients with renal impairment should be monitored closely when taking fenquizone. Dose adjustments may be necessary depending on the severity of renal dysfunction.Â
Elderly Patients: Elderly individuals may be more sensitive to the effects of fenquizone. Lower initial doses and careful titration may be required in this population.Â
Cardiovascular Conditions: fenquizone can cause changes in blood pressure and heart rate. Patients with pre-existing cardiovascular conditions should be monitored closely while taking this medication.Â
Pregnancy and Lactation: The safety of fenquizone during pregnancy and breastfeeding is not well-established. It should only be used during pregnancy or lactation if the potential benefits outweigh the risks, and under the guidance of a healthcare provider.
Comorbidities:Â
Respiratory Conditions: fenquizone has the potential to cause respiratory depression, especially at higher doses. Individuals with pre-existing respiratory conditions such as COPD or asthma may be more susceptible to these effects. Careful monitoring is required in such cases.Â
Neurological Disorders: fenquizone can cause dizziness and drowsiness. Individuals with epilepsy or a history of seizures may need extra caution when using this medication.Â
Psychiatric Disorders: Patients with psychiatric disorders, especially those that affect mood or cognition, may experience changes in their mental state while taking fenquizone. Close monitoring is necessary in these cases.Â
Alcohol and Substance Abuse: Patients with a history of alcohol or substance abuse should be closely monitored while using fenquizone, as it may interact with these substances or exacerbate withdrawal symptoms.Â
Pregnancy consideration: pregnancy category: not assignedÂ
Lactation: excreted into breast milk: unknown Â
Pregnancy category:Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.  Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.Â
Category N: There is no data available for the drug under this category.Â
Pharmacology:Â
fenquizone is a medication with muscle relaxant and anti-spasmodic properties. Its pharmacology involves its action on the central nervous system (CNS). fenquizone is thought to work by depressing nerve transmission in spinal cord, which leads to reduced muscle spasms and improved muscle relaxation. It primarily affects the gamma-aminobutyric acid (GABA) neurotransmitter system, increasing inhibitory signals in the CNS. This results in a calming effect on the muscles, reducing muscle tension and spasms. fenquizone is typically used in the treatment of musculoskeletal conditions characterized by excessive muscle contractions and spasticity. Â
Pharmacodynamics:Â
Muscle Relaxation: fenquizone acts centrally in the CNS to reduce muscle tension and spasms. It achieves this by depressing nerve transmission in the spinal cord, which leads to decreased muscle contractions and improved muscle relaxation.Â
Gamma-Aminobutyric Acid (GABA) Modulation: fenquizone is believed to enhance inhibitory effects of neurotransmitter GABA in the CNS. GABA is an important neurotransmitter that reduces neural activity, promoting a calming effect on the muscles.Â
Sedation: One of the side effects of fenquizone is sedation. It can cause drowsiness and may impair cognitive and motor skills. This sedative effect is an important consideration when using the medication.
Pharmacokinetics:Â
AbsorptionÂ
fenquizone is typically administered orally in tablet form. After oral administration, it is absorbed through the gastrointestinal tract. The rate of absorption can vary among individuals and influenced by factors like the formulation of the medication and the presence of food in the stomach.Â
DistributionÂ
Once absorbed, fenquizone is distributed throughout the body. It is likely to cross blood-brain barrier due to its central nervous system effects. Â
MetabolismÂ
The metabolism of fenquizone is not extensively studied, and there is limited information about its metabolic pathways. It is believed to undergo hepatic (liver) metabolism, but the specific enzymes and metabolites involved are not well-characterized.Â
Elimination and excretionÂ
The excretion of fenquizone is primarily through renal (kidney) elimination. Some of the drug and its metabolites are excreted in the urine. The exact elimination half-life and clearance rates may vary among individuals.Â
Administration:Â
Dosage: Take fenquizone exactly as prescribed by your healthcare provider. The dosage can vary based on condition being treated and individual factors. Â
Timing: fenquizone is usually taken with or after meals to minimize stomach upset. Follow your healthcare provider’s recommendations regarding when to take it.Â
Duration: Continue taking fenquizone for the full duration prescribed by healthcare provider, even if your symptoms improve. Stopping the medication prematurely may not effectively manage your condition.Â
Storage: Store fenquizone tablets at room temperature, away from moisture and heat. Follow any specific storage instructions provided with your medication.Â
Patient information leafletÂ
Generic Name: fenquizoneÂ
Pronounced: (fen-kwye-zone)Â Â
Why do we use fenquizone?Â
Pain Relief: fenquizone has been used to alleviate mild to moderate pain, like dental pain, headaches, and musculoskeletal pain.Â
Fever Reduction: It is used to lower fever associated with various illnesses and infections.Â
Inflammation: fenquizone may have anti-inflammatory properties, and it has been used to reduce inflammation in conditions like arthritis.Â
Postoperative Pain: In some cases, it has been used to manage pain after surgical procedures.Â
Rheumatic Conditions: fenquizone has been used to relieve pain and inflammation in certain rheumatic conditions, although its use in this context has diminished over the years.Â
fenquizone is a medication with anti-inflammatory and analgesic properties. It is primarily used to relieve pain and reduce inflammation. The spectrum of its action is focused on providing relief from pain and inflammation in various conditions, but it is not a broad-spectrum antibiotic or a medication with a wide range of effects like some other drugs. Instead, it is used for its specific anti-inflammatory and analgesic actions.Â
Dosing & Uses
Drug Interaction
Adverse Reaction
Frequency not definedÂ
Electrolyte disturbancesÂ
HypotensionÂ
HeadacheÂ
WeaknessÂ
DizzinessÂ
Black Box Warning
Black Box Warning:Â
There were no black box warnings associated with fenoverine.Â
Contraindication / Caution
Contraindication/Caution:Â
Contraindication:Â
Hypersensitivity: Avoid fenquizone if the patient has a known hypersensitivity or allergy to fenquizone or any of its components.Â
Myasthenia Gravis: fenquizone may worsen the symptoms of myasthenia gravis, a neuromuscular disorder. It is contraindicated in individuals with this condition.Â
Porphyria: fenquizone can trigger acute attacks of porphyria, a group of rare genetic disorders affecting the nervous system or skin. It should be avoided in patients with porphyria.Â
Concurrent Use of Alcohol or CNS Depressants: fenquizone can enhance the depressant effects of alcohol and other central nervous system (CNS) depressants. It should not be used in combination with these substances.
Caution:Â
Hepatic Impairment: fenquizone is metabolized in the liver, and its clearance may be impaired in individuals with liver disease. Use fenquizone with caution in patients with mild to moderate hepatic impairment and avoid it in those with severe impairment.Â
Renal Impairment: Patients with renal impairment should be monitored closely when taking fenquizone. Dose adjustments may be necessary depending on the severity of renal dysfunction.Â
Elderly Patients: Elderly individuals may be more sensitive to the effects of fenquizone. Lower initial doses and careful titration may be required in this population.Â
Cardiovascular Conditions: fenquizone can cause changes in blood pressure and heart rate. Patients with pre-existing cardiovascular conditions should be monitored closely while taking this medication.Â
Pregnancy and Lactation: The safety of fenquizone during pregnancy and breastfeeding is not well-established. It should only be used during pregnancy or lactation if the potential benefits outweigh the risks, and under the guidance of a healthcare provider.
Comorbidities:Â
Respiratory Conditions: fenquizone has the potential to cause respiratory depression, especially at higher doses. Individuals with pre-existing respiratory conditions such as COPD or asthma may be more susceptible to these effects. Careful monitoring is required in such cases.Â
Neurological Disorders: fenquizone can cause dizziness and drowsiness. Individuals with epilepsy or a history of seizures may need extra caution when using this medication.Â
Psychiatric Disorders: Patients with psychiatric disorders, especially those that affect mood or cognition, may experience changes in their mental state while taking fenquizone. Close monitoring is necessary in these cases.Â
Alcohol and Substance Abuse: Patients with a history of alcohol or substance abuse should be closely monitored while using fenquizone, as it may interact with these substances or exacerbate withdrawal symptoms.Â
Pregnancy / Lactation
Pregnancy consideration: pregnancy category: not assignedÂ
Lactation: excreted into breast milk: unknown Â
Pregnancy category:Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.  Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.Â
Category N: There is no data available for the drug under this category.Â
Pharmacology
Pharmacology:Â
fenquizone is a medication with muscle relaxant and anti-spasmodic properties. Its pharmacology involves its action on the central nervous system (CNS). fenquizone is thought to work by depressing nerve transmission in spinal cord, which leads to reduced muscle spasms and improved muscle relaxation. It primarily affects the gamma-aminobutyric acid (GABA) neurotransmitter system, increasing inhibitory signals in the CNS. This results in a calming effect on the muscles, reducing muscle tension and spasms. fenquizone is typically used in the treatment of musculoskeletal conditions characterized by excessive muscle contractions and spasticity. Â
Pharmacodynamics:Â
Muscle Relaxation: fenquizone acts centrally in the CNS to reduce muscle tension and spasms. It achieves this by depressing nerve transmission in the spinal cord, which leads to decreased muscle contractions and improved muscle relaxation.Â
Gamma-Aminobutyric Acid (GABA) Modulation: fenquizone is believed to enhance inhibitory effects of neurotransmitter GABA in the CNS. GABA is an important neurotransmitter that reduces neural activity, promoting a calming effect on the muscles.Â
Sedation: One of the side effects of fenquizone is sedation. It can cause drowsiness and may impair cognitive and motor skills. This sedative effect is an important consideration when using the medication.
Pharmacokinetics:Â
AbsorptionÂ
fenquizone is typically administered orally in tablet form. After oral administration, it is absorbed through the gastrointestinal tract. The rate of absorption can vary among individuals and influenced by factors like the formulation of the medication and the presence of food in the stomach.Â
DistributionÂ
Once absorbed, fenquizone is distributed throughout the body. It is likely to cross blood-brain barrier due to its central nervous system effects. Â
MetabolismÂ
The metabolism of fenquizone is not extensively studied, and there is limited information about its metabolic pathways. It is believed to undergo hepatic (liver) metabolism, but the specific enzymes and metabolites involved are not well-characterized.Â
Elimination and excretionÂ
The excretion of fenquizone is primarily through renal (kidney) elimination. Some of the drug and its metabolites are excreted in the urine. The exact elimination half-life and clearance rates may vary among individuals.Â
Adminstartion
Administration:Â
Dosage: Take fenquizone exactly as prescribed by your healthcare provider. The dosage can vary based on condition being treated and individual factors. Â
Timing: fenquizone is usually taken with or after meals to minimize stomach upset. Follow your healthcare provider’s recommendations regarding when to take it.Â
Duration: Continue taking fenquizone for the full duration prescribed by healthcare provider, even if your symptoms improve. Stopping the medication prematurely may not effectively manage your condition.Â
Storage: Store fenquizone tablets at room temperature, away from moisture and heat. Follow any specific storage instructions provided with your medication.Â
Patient Information Leaflet
Patient information leafletÂ
Generic Name: fenquizoneÂ
Pronounced: (fen-kwye-zone)Â Â
Why do we use fenquizone?Â
Pain Relief: fenquizone has been used to alleviate mild to moderate pain, like dental pain, headaches, and musculoskeletal pain.Â
Fever Reduction: It is used to lower fever associated with various illnesses and infections.Â
Inflammation: fenquizone may have anti-inflammatory properties, and it has been used to reduce inflammation in conditions like arthritis.Â
Postoperative Pain: In some cases, it has been used to manage pain after surgical procedures.Â
Rheumatic Conditions: fenquizone has been used to relieve pain and inflammation in certain rheumatic conditions, although its use in this context has diminished over the years.Â
Loading...
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.